Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Mazen S. Zenati"'
Autor:
Amer H. Zureikat, Ibrahim Nassour, David L Bartlett, Annissa Desilva, Lance A. Liotta, Aatur D. Singhi, Virginia Espina, Alessandro Paniccia, Samer AlMasri, Nathan Bahary, Brian A. Boone, Herbert J. Zeh, Patricia Loughran, Michael T. Lotze, Mazen S. Zenati
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 20, Pp 7233-7241 (2021)
Cancer Medicine, Vol 10, Iss 20, Pp 7233-7241 (2021)
Introduction Preoperative autophagy inhibition with hydroxychloroquine (HCQ) in combination with gemcitabine in pancreatic adenocarcinoma (PDAC) has been shown to be safe and effective in inducing a serum biomarker response and increase resection rat
Autor:
Shimena R Li, Terence O'Keeffe, Mazen S. Zenati, Joshua D. Brown, Katherine M. Reitz, Matthew D. Neal, Gary Vercruysse, Bellal Joseph, Raminder Nirula, Francis X. Guyette, Brian S. Zuckerbraun, Brian J. Eastridge, Jason L. Sperry
Publikováno v:
Ann Surg
OBJECTIVE We sought to characterize the timing of administration of prehospital tranexamic acid (TXA) and associated outcome benefits. BACKGROUND TXA has been shown to be safe in the prehospital setting post-injury. METHODS We performed a secondary a
Autor:
Mazen S. Zenati, Amer H. Zureikat, Melissa E. Hogg, Amr I. Al Abbas, Herbert J. Zeh, Jae Pil Jung, Caroline J. Reiser, Ahmad Hamad
Publikováno v:
Ann Surg Oncol
INTRODUCTION: Optimal cut-offs for CA19-9 response after neoadjuvant therapy (NT) for pancreatic adenocarcinoma (PDAC) are not well characterized. This study aims to analyze the relationship of serum CA19-9 with other markers of response and identify
Autor:
Caroline J. Rieser, David L. Bartlett, Asmita Chopra, Kenneth K.W. Lee, Sowmya Narayanan, Amer H. Zureikat, Alessandro Paniccia, Samer AlMasri, Tracy Daum, Mazen S. Zenati, Katelyn Smith, Nathan Bahary, Vivianne Oyefusi, Ibrahim Nassour
Publikováno v:
J Surg Oncol
BACKGROUND AND OBJECTIVES Neoadjuvant chemotherapy (NAT) for pancreatic adenocarcinoma (PDAC) is increasingly being utilized. However, a significant number of patients will experience early recurrence, possibly negating the benefit of surgery. We aim
Autor:
Deepa Magge, Amer H. Zureikat, Ahmad Hamad, Mazen S. Zenati, Herbert J. Zeh, Melissa E. Hogg, Caroline J. Rieser
Publikováno v:
HPB. 20:1172-1180
NSQIP data show that half of distal pancreatectomies (DP) are performed by a minimally invasive approach (MIS). Advantages have been demonstrated for MIS DP, yet comparative cost data are limited. Outcomes and cost were compared in patients undergoin
Autor:
Samer, AlMasri, Mazen S, Zenati, Georgios I, Papachristou, Adam, Slivka, Michael, Sanders, Jennifer, Chennat, Mordechai, Rabinowitz, Asif, Khalid, Andres, Gelrud, John, Nasr, Savreet, Sarkaria, Rohit, Das, Kenneth K, Lee, Wolfgang, Schraut, Steve J, Hughes, A James, Moser, Alessandro, Paniccia, Melissa E, Hogg, Herbert J, Zeh, Amer H, Zureikat
Publikováno v:
Surgical endoscopy. 36(1)
Treatment of pancreaticobiliary pathology following Roux-en-Y gastric bypass (RYGB) poses significant technical challenges. Laparoscopic-assisted endoscopic retrograde cholangiopancreatography (LA-ERCP) can overcome those anatomical hurdles, allowing
Autor:
Nathan Bahary, Caroline J. Rieser, Herbert J. Zeh, Mazen S. Zenati, Kenneth K. Lee, Amer H. Zureikat, Hao Liu, Aatur D. Singhi, Amr Al-abbas, Melissa E. Hogg
Publikováno v:
Ann Surg Oncol
BACKGROUND: Neoadjuvant therapy (NAT) is increasingly utilized for pancreatic cancer, however the added benefit of adjuvant therapy (AT) in this setting is unknown. We hypothesized that the magnitude of CA19-9 response to NAT can guide the need for f
Autor:
Matthew P. Holtzman, Melissa E. Hogg, J. Wallis Marsh, David L. Bartlett, James F. Pingpank, Mashaal Dhir, Amer H. Zureikat, David A. Geller, M. Haroon A. Choudry, Herbert J. Zeh, Heather L. Jones, Mazen S. Zenati, Nathan Bahary, Allan Tsung
Publikováno v:
Annals of Surgical Oncology. 25:550-557
In the era of modern effective systemic chemotherapy, the comparative effectiveness of hepatic artery infusion (HAI) versus selective internal radiation therapy (yttrium-90 [Y90]) for pretreated patients with isolated unresectable colorectal liver me
Autor:
Jennifer Steve, Herbert J. Zeh, Mazen S. Zenati, Amer H. Zureikat, David L. Bartlett, Mark D. Girgis, Melissa E. Hogg
Publikováno v:
HPB. 19:93-98
The aim was to evaluate the impact of obesity on perioperative outcomes in patients undergoing robotic pancreaticoduodenectomy (RPD) compared to open pancreaticoduodenectomy (OPD).A retrospective review of all pancreaticoduodenectomies from 9/2011 to
Autor:
Ahmed Salem, Trang Nguyen, Susan J. Stocker, Clifford S. Cho, Yuan Liu, Theresa W. Gillespie, Sharon M. Weber, Mark S. Talamonti, Lauren M. Postlewait, Stephanie T Lumpkin, David J. Bentrem, Syed A. Ahmad, Mazen S. Zenati, Daniel E. Abbott, Shishir K. Maithel, Herbert J. Zeh, Melissa E. Hogg, Brent T. Xia, Hong J. Kim, Hari B. Keshava, Amer H. Zureikat, R. Matthew Walsh, Jennifer Steve, Sricharan Chalikonda, David A. Kooby
Publikováno v:
Annals of Surgery. 264:640-649
Limited data exist comparing robotic and open approaches to pancreaticoduodenectomy (PD). We performed a multicenter comparison of perioperative outcomes of robotic PD (RPD) and open PD (OPD).Perioperative data for patients who underwent postlearning